What Makes Zoetis (ZTS) an Investment Bet?

1 hour ago 1

Soumya Eswaran

Wed, March 18, 2026 astatine 8:37 AM CDT 3 min read

Diamond Hill Capital, an concern absorption company, released its “Mid Strategy” fourth-quarter 2025 capitalist letter. A transcript of the missive tin beryllium downloaded here. The 4th fourth posted different play of favorable gains for equity markets, with tiny and ample headdress positions being stronger performers, returning 2.19% and 2.41%. While the mid-cap scope was a comparative laggard, with the Russell Mid Cap Index returning 0.16%. The Strategy returned 3.65% (net) successful Q4, compared to 0.16% instrumentality for the Russell Midcap Index. YTD, the strategy returned 13.47%, outperforming the 10.60% instrumentality for the Index. In 2025, AI-related spending remained a cardinal operator successful equity markets, though December saw a intermission arsenic investors became much cautious astir AI developments and imaginable marketplace bubbles. Given the elevated valuation successful the equity market, the Strategy is well-positioned for ongoing levels of heightened uncertainty going forward. Please reappraisal the Strategy’s apical 5 holdings to summation insights into their cardinal selections for 2025.

In its fourth-quarter 2025 capitalist letter, Diamond Hill Mid Strategy highlighted stocks similar Zoetis Inc. (NYSE:ZTS). Zoetis Inc. (NYSE:ZTS) is an carnal wellness institution focused connected carnal wellness medications, vaccines, and diagnostic products. On March 17, 2026, Zoetis Inc. (NYSE:ZTS) banal closed astatine $121.68 per share. Zoetis Inc. (NYSE:ZTS) delivered a -5.77% instrumentality successful the past month, and its shares mislaid 25.69% implicit the past 12 months. Zoetis Inc. (NYSE:ZTS) has a marketplace capitalization of astir $53.624 billion.

Diamond Hill Mid Strategy stated the pursuing regarding Zoetis Inc. (NYSE:ZTS) successful its 4th fourth 2025 capitalist letter:

"Zoetis Inc. (NYSE:ZTS) is simply a person successful the carnal wellness marketplace with starring products for companion animals (pets) and livestock. The institution has a wide portfolio with aggregate maturation drivers and a beardown pipeline to code respective undertreated favored conditions. Concerns astir 1 of its arthritis drugs utilized successful dogs person pressured the stock terms recently, allowing america to present a presumption beneath our estimation of intrinsic value."

Is Zoetis a Unique Dividend Play successful the Pharma Space for 2025?

Zoetis Inc. (NYSE:ZTS) is not connected our database of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 69 hedge money portfolios held Zoetis Inc. (NYSE:ZTS) astatine the extremity of the 4th quarter, up from 72 successful the erstwhile quarter. While we admit the imaginable of Zoetis Inc. (NYSE:ZTS) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

Read Entire Article